glp-1 incretin effect Incretins as Multi–Disease State Treatments The incretin effect in healthy

Not all are monitored

It is by no means an overstatement to say that this approach was wildly successful in unlocking GLP-1s therapeutic potential

391 GLP-1 and GLP-1 analogs exert their effects on food intake and body weight through a myriad of neural substrates, encompassing several hypothalamic nuclei (including the arcuate nucleus of the hypothalamus, periventricular hypothalamus, and lateral hypothalamic area), hindbrain nuclei (such as the parabrachial nucleus and medial nucleus tractus solitarius), the ventral subregion of the hippocampus (vHP), and nuclei embedded within the mesolimbic reward circuitry (including the ventral tegmental area, VTA, and nucleus accumbens, NAc)

Older GLP-1 medications including liraglutide, dulaglutide, and exenatide have not shown statistically significant increases in hair loss reports